The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The company’s mRNA flu shot, if approved, could be available for the 2026-27 flu season. on.wsj.com/4qGYG4w https://on.wsj.com/4qGYG4w
2026-02-18T14:15:25.248Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.